Form 424B3 USVC Venture Capital
Filed Pursuant to Rule
Registration No. 333-255702

Common Shares of Beneficial Interest
Supplement dated April 9, 2026 to the
Prospectus dated October 29, 2025, as supplemented March 27, 2026
This supplement amends the prospectus of USVC Venture Capital Access Fund (the “Fund”). You should read this supplement in conjunction with the prospectus and retain it for future reference. Capitalized terms and certain other terms used in this supplement, unless otherwise defined in this supplement, have the meanings assigned to them in the prospectus.
The Fund’s prospectus is revised as follows, effective immediately:
The following subsection is added before the “Investment Objective, Principal Strategies, Methodology and Policies – The Fund May Change Its Investment Objective, Strategies, Policies, Restrictions, and Techniques” section:
The Investment Process
The Investment Adviser’s Investment Committee (the “Investment Committee”) serves as a governance and oversight body for investment decisions made on behalf of the Fund and provides structured decision-making, risk management and conflict-of-interest controls for the Fund. The Investment Committee conducts a strategy review at least twice per calendar year, covering portfolio composition, performance attribution, concentration, and risk parameter compliance, pipeline, and any recommended changes to the strategy framework.
The Investment Committee currently consists of three voting members, Ankur Nagpal, Naval Ravikant and Erik Syvertsen. Naval Ravikant currently serves as the Chairman of the Investment Committee. Subject to the Fund’s investment objectives, restrictions and the strategy framework approved by the Investment Committee, the Fund’s portfolio manager, Ankur Nagpal, selects and evaluates individual Investment Vehicles and Portfolio Companies.
The “Management of the Fund – Portfolio Manager” section is deleted in its entirety and replaced with the following:
Portfolio Management Team
The Investment Adviser’s Portfolio Management Team is principally responsible for the investment management of the Fund. The Fund is also supported by the Investment Committee. See below for biographies of the portfolio manager and the other members of the Investment Committee.
Portfolio Manager
Ankur Nagpal. Ankur Nagpal serves as USVC’s portfolio manager and as a member of the Investment Committee. Mr. Nagpal has experience as both an investor and founder. He is the Founding Partner of Vibe Capital, a venture fund through which he has invested in more than 200 early-stage technology companies globally across two funds totaling over $60 million. Mr. Nagpal is also a serial entrepreneur. He founded Teachable, Inc., a platform for creators, which he sold for $250 million in 2020, and Carry Technologies, Inc. (“Carry”), a financial technology company supporting retirement account investing. He holds a Bachelor of Arts and Bachelor of Science in Economics, Electrical Engineering, and Computer Science from the University of California, Berkeley.
Other Investment Committee Members
Naval Ravikant. Naval Ravikant is the Chairman of the Fund’s Investment Committee. Mr. Ravikant is the co-founder and Chairman of AngelList, manager of multiple VC funds, and an early-stage investor in companies including Uber, Twitter, and Notion. Mr. Ravikant holds a Bachelor of Science in Computer Science and Economics from Dartmouth College.
Erik Syvertsen. Erik Syvertsen serves as Chair of the Board of Trustees of the Fund, Chief Executive Officer of the Fund and a member of the Investment Committee. Mr. Syvertsen also serves as Chief Legal Officer of AngelList and Chief Executive Officer of the Investment Adviser. Mr. Syvertsen holds an M.B.A. from Columbia Business School and received a J.D., cum laude, from Benjamin N. Cardozo School of Law.
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
XBRL TAXONOMY EXTENSION LABEL LINKBASE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H3 Zoom Closes Oversubscribed USD$3.6 Million Series A Round to Scale AI-Powered Inspection Intelligence Across Asia
- Xilam Films Greenlights Feature Adaptation of The Wolf with Bidibul Productions, Goodfellas, ARP and Crunchyroll on Board
- Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share